SOPHiA GENETICS (SOPH) Short Interest Ratio & Short Volume → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free SOPH Stock Alerts $5.07 +0.01 (+0.20%) (As of 11:32 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media SOPHiA GENETICS Short Interest DataCurrent Short Volume52,600 sharesPrevious Short Volume43,000 sharesChange Vs. Previous Month+22.33%Dollar Volume Sold Short$259,318.00Short Interest Ratio / Days to Cover1.0Last Record DateMarch 31, 2024Outstanding Shares65,230,000 sharesFloat Size46,260,000 sharesShort Percent of Float0.11%Today's Trading Volume7,138 sharesAverage Trading Volume60,104 sharesToday's Volume Vs. Average12% Short Selling SOPHiA GENETICS ? Sign up to receive the latest short interest report for SOPHiA GENETICS and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSOPH Short Interest Over TimeSOPH Days to Cover Over TimeSOPH Percentage of Float Shorted Over Time Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry SOPHiA GENETICS Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202452,600 shares $259,318.00 +22.3%0.1%1 $4.93 3/15/202443,000 shares $191,780.00 -28.6%0.1%0.9 $4.46 2/29/202460,200 shares $301,000.00 -0.7%0.1%1.3 $5.00 2/15/202460,600 shares $285,426.00 -2.4%0.1%1.7 $4.71 1/31/202462,100 shares $285,039.00 +7.4%0.1%1.7 $4.59 1/15/202457,800 shares $302,294.00 +19.2%0.1%1.3 $5.23 Get the Latest News and Ratings for SOPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for SOPHiA GENETICS and its competitors with MarketBeat's FREE daily newsletter. 12/31/202348,500 shares $228,435.00 -4.9%0.1%1.2 $4.71 12/15/202351,000 shares $223,380.00 +50.4%0.1%1.5 $4.38 11/30/202333,900 shares $136,278.00 +52.7%0.1%1.1 $4.02 11/15/202322,200 shares $86,802.00 -51.7%0.1%0.6 $3.91 10/31/202346,000 shares $169,740.00 +59.2%0.1%1 $3.69 10/15/202328,900 shares $89,879.00 -20.2%0.1%0.6 $3.11 9/30/202336,200 shares $92,129.00 +35.6%0.1%0.7 $2.55 9/15/202326,700 shares $64,347.00 -4.3%0.1%0.5 $2.41 8/31/202327,900 shares $68,076.00 +1.1%0.1%0.5 $2.44 8/15/202327,600 shares $80,040.00 +22.1%0.1%0.5 $2.90 7/31/202322,600 shares $85,880.00 -27.6%0.1%0.3 $3.80 7/15/202331,200 shares $142,896.00 -12.9%0.1%0.5 $4.58 6/30/202335,800 shares $160,384.00 -23.2%0.1%0.6 $4.48 6/15/202346,600 shares $192,458.00 -7.5%0.1%0.7 $4.13 5/31/202350,400 shares $234,864.00 -44.6%0.1%0.4 $4.66 5/15/202390,900 shares $405,414.00 -15.6%0.2%0.7 $4.46 4/30/2023107,700 shares $521,268.00 +5.1%0.2%1 $4.84 4/15/2023102,500 shares $447,925.00 -11.6%0.2%0.8 $4.37 3/31/2023116,000 shares $576,520.00 -74.2%0.3%0.9 $4.97 3/15/2023449,700 shares $2.19 million +1,207.3%1.0%3.5 $4.86 2/28/202334,400 shares $89,440.00 -17.7%0.1%0.4 $2.60 2/15/202341,800 shares $112,024.00 +7.5%0.1%0.6 $2.68 1/31/202338,900 shares $116,700.00 -31.5%0.1%0.5 $3.00 1/15/202356,800 shares $177,784.00 +3.5%0.1%0.6 $3.13 12/30/202254,900 shares $113,094.00 +43.7%0.1%0.7 $2.06 12/15/202238,200 shares $89,006.00 -34.5%0.1%0.5 $2.33 11/30/202258,300 shares $134,673.00 -3.0%0.1%0.6 $2.31 11/15/202260,100 shares $123,205.00 +4.0%0.1%0.6 $2.05 10/31/202257,800 shares $127,160.00 -25.3%0.1%0.6 $2.20 10/15/202277,400 shares $175,698.00 -18.2%0.2%0.8 $2.27 9/30/202294,600 shares $248,798.00 No Change0.2%1.1 $2.63 9/15/202294,600 shares $255,420.00 -32.1%0.2%1.1 $2.70 8/31/2022139,300 shares $458,297.00 +10.3%0.3%1.5 $3.29 8/15/2022126,300 shares $568,350.00 -23.8%0.3%1.4 $4.50This Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry SOPH Short Interest - Frequently Asked Questions What is SOPHiA GENETICS's current short interest? Short interest is the volume of SOPHiA GENETICS shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 52,600 shares of SOPH short. 0.11% of SOPHiA GENETICS's shares are currently sold short. Learn More on SOPHiA GENETICS's current short interest. What is a good short interest ratio for SOPHiA GENETICS? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SOPH shares currently have a short interest ratio of 1.0. Learn More on SOPHiA GENETICS's short interest ratio. What is a good short interest percentage for SOPHiA GENETICS? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.11% of SOPHiA GENETICS's floating shares are currently sold short. Is SOPHiA GENETICS's short interest increasing or decreasing? SOPHiA GENETICS saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 52,600 shares, an increase of 22.3% from the previous total of 43,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is SOPHiA GENETICS's float size? SOPHiA GENETICS currently has issued a total of 65,230,000 shares. Some of SOPHiA GENETICS's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. SOPHiA GENETICS currently has a public float of 46,260,000 shares. How does SOPHiA GENETICS's short interest compare to its competitors? 0.11% of SOPHiA GENETICS's shares are currently sold short. Here is how the short interest of companies compare to SOPHiA GENETICS: Invivyd, Inc. (3.85%), Ventyx Biosciences, Inc. (19.58%), Anavex Life Sciences Corp. (26.94%), TScan Therapeutics, Inc. (0.60%), Monte Rosa Therapeutics, Inc. (5.31%), MeiraGTx Holdings plc (1.79%), Tenaya Therapeutics, Inc. (4.99%), Aura Biosciences, Inc. (6.17%), Caribou Biosciences, Inc. (12.85%), Jasper Therapeutics, Inc. (3.84%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short SOPHiA GENETICS stock? Short selling SOPH is an investing strategy that aims to generate trading profit from SOPHiA GENETICS as its price is falling. SOPH shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against SOPHiA GENETICS? A short squeeze for SOPHiA GENETICS occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SOPH, which in turn drives the price of the stock up even further. How often is SOPHiA GENETICS's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SOPH, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: IVVD Short Interest Data VTYX Short Interest Data AVXL Short Interest Data TCRX Short Interest Data GLUE Short Interest Data MGTX Short Interest Data TNYA Short Interest Data AURA Short Interest Data CRBU Short Interest Data JSPR Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SOPH) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe Greatest Bull Market in Crypto History…Weiss RatingsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals